Lipid content in hepatic and gonadal adipose tissue parallel aortic cholesterol accumulation in mice fed diets with different omega-6 PUFA to EPA plus DHA ratios.

[1]  A. Wierzbicki,et al.  Nonalcoholic fatty liver disease and lipids , 2012, Current opinion in lipidology.

[2]  M. Fuchs,et al.  The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis. , 2012, Clinics in liver disease.

[3]  V. Christiaens,et al.  CD36 promotes adipocyte differentiation and adipogenesis. , 2012, Biochimica et biophysica acta.

[4]  D. Mikhailidis,et al.  Triglycerides: a case for treatment? , 2012, Current opinion in cardiology.

[5]  E. Bonora,et al.  Increased risk of cardiovascular disease and chronic kidney disease in NAFLD , 2012, Nature Reviews Gastroenterology &Hepatology.

[6]  Christopher D Byrne,et al.  Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? , 2012, European heart journal.

[7]  K. Kristiansen,et al.  High-glycemic index carbohydrates abrogate the antiobesity effect of fish oil in mice. , 2012, American journal of physiology. Endocrinology and metabolism.

[8]  Catriona A. Burdon,et al.  Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. , 2012, Journal of hepatology.

[9]  H. Sampath,et al.  The role of stearoyl‐CoA desaturase in obesity, insulin resistance, and inflammation , 2011, Annals of the New York Academy of Sciences.

[10]  J. Harwood,et al.  Eicosapentaenoic Acid and Docosahexaenoic Acid Regulate Modified LDL Uptake and Macropinocytosis in Human Macrophages , 2011, Lipids.

[11]  K. Swedberg.  n-3 Fatty acids in cardiovascular disease. , 2011, The New England journal of medicine.

[12]  K. Nuernberg,et al.  Dietary n-3 Fatty Acids Significantly Suppress Lipogenesis in Bovine Muscle and Adipose Tissue: A Functional Genomics Approach , 2011, Lipids.

[13]  T. Kowalski,et al.  Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity , 2011, Journal of Lipid Research.

[14]  J. Buckley,et al.  Long-Chain Omega-3 Polyunsaturated Fatty Acids May Be Beneficial for Reducing Obesity—A Review , 2010, Nutrients.

[15]  T. Nakayama,et al.  Inflammation, a Link between Obesity and Cardiovascular Disease , 2010, Mediators of inflammation.

[16]  M. Reilly,et al.  Adipocyte Modulation of High-Density Lipoprotein Cholesterol , 2010, Circulation.

[17]  Hyoun-ju Kim,et al.  Anti-obesity effect of fish oil and fish oil-fenofibrate combination in female KK mice. , 2009, Journal of atherosclerosis and thrombosis.

[18]  K. Adeli,et al.  Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. , 2009, Clinical biochemistry.

[19]  A. Lichtenstein,et al.  Reduction in dietary omega-6 polyunsaturated fatty acids: eicosapentaenoic acid plus docosahexaenoic acid ratio minimizes atherosclerotic lesion formation and inflammatory response in the LDL receptor null mouse. , 2009, Atherosclerosis.

[20]  S. Wakil,et al.  Fatty acid metabolism: target for metabolic syndrome This work is supported by grants from the National Institute of Health (GM-63115), the Hefni Technical Training Foundation, and the Medallion Foundation. Published, JLR Papers in Press, December 1, 2008. , 2009, Journal of Lipid Research.

[21]  P. Luoma.  Cytochrome P450 and gene activation—from pharmacology to cholesterol elimination and regression of atherosclerosis , 2008, European Journal of Clinical Pharmacology.

[22]  P. Kris-Etherton,et al.  N-3 fatty acids: food or supplements? , 2008, Journal of the American Dietetic Association.

[23]  M. Furuhashi,et al.  Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. , 2008, The Journal of clinical investigation.

[24]  A. Lichtenstein,et al.  Novel soybean oils with different fatty acid profiles alter cardiovascular disease risk factors in moderately hyperlipidemic subjects. , 2006, The American journal of clinical nutrition.

[25]  C. Napoli,et al.  Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Shiro Watanabe,et al.  Cholesterol synthesis in mice is suppressed but lipofuscin formation is not affected by long-term feeding of n-3 fatty acid-enriched oils compared with lard and n-6 fatty acid-enriched oils. , 2003, Biological & pharmaceutical bulletin.

[27]  A. Remaley,et al.  Lipopolysaccharide Down Regulates Both Scavenger Receptor B1 and ATP Binding Cassette Transporter A1 in RAW Cells , 2002, Infection and Immunity.

[28]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[29]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[30]  J. Borén,et al.  ATVB In Focus Metabolic Syndrome and Atherosclerosis , 2008 .